0001235802-17-000173.txt : 20171221
0001235802-17-000173.hdr.sgml : 20171221
20171221160859
ACCESSION NUMBER: 0001235802-17-000173
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171219
FILED AS OF DATE: 20171221
DATE AS OF CHANGE: 20171221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mashaal Michael Y
CENTRAL INDEX KEY: 0001642607
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33818
FILM NUMBER: 171269559
MAIL ADDRESS:
STREET 1: 309 WAVERLEY OAKS RD., SUITE 105
CITY: WALTHAM
STATE: MA
ZIP: 02452
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReShape Lifesciences Inc.
CENTRAL INDEX KEY: 0001371217
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 481293684
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2800 Patton Rd
CITY: St Paul
STATE: MN
ZIP: 55113
BUSINESS PHONE: 651-634-3003
MAIL ADDRESS:
STREET 1: 2800 Patton Rd
CITY: St Paul
STATE: MN
ZIP: 55113
FORMER COMPANY:
FORMER CONFORMED NAME: EnteroMedics Inc
DATE OF NAME CHANGE: 20060802
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-12-19
0
0001371217
ReShape Lifesciences Inc.
RSLS
0001642607
Mashaal Michael Y
2800 PATTON ROAD
ST. PAUL
MN
55113
1
0
0
0
Common Stock, $0.01 par value per share
2017-12-19
4
C
0
2048700
A
2617077
I
See footnote
Series C Convertible Preferred Stock, $0.01 par value
2017-12-19
4
S
0
20487
D
26200
I
See footnote
Each share of Series C Convertible Preferred Stock converted into 100 shares of common stock.
Consists of shares held directly by HealthCor Partners Fund II, L.P. ("HCPII"). The shares held by HCPII may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. Dr. Mashaal is a managing director of HealthCor Partners Management, L.P. ("HCP Management"), which is the investment manager to HCPII, and may be deemed to have shared voting and investment power over such shares. Each of HCPLP, HCP2LP, HCPGP, HCP Management and Dr. Mashaal hereby disclaims any beneficial ownership of shares held by HCPII except to the extent of any pecuniary interest therein.
/s/ Scott P. Youngstrom, attorney-in-fact
2017-12-21